TD ASSET MANAGEMENT INC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2023$686,086
-2.1%
26,990
+39.2%
0.00%0.0%
Q1 2023$700,949
+8.7%
19,390
+19.0%
0.00%0.0%
Q4 2022$645,084
-61.0%
16,290
-53.4%
0.00%
-50.0%
Q3 2022$1,654,000
+8.0%
34,9400.0%0.00%0.0%
Q2 2022$1,531,000
-49.7%
34,940
-16.9%
0.00%
-33.3%
Q1 2022$3,042,000
-22.9%
42,052
-13.6%
0.00%0.0%
Q4 2021$3,944,000
-8.4%
48,650
+31.5%
0.00%
-25.0%
Q3 2021$4,306,000
-34.4%
36,997
-12.6%
0.00%
-42.9%
Q2 2021$6,564,000
-3.3%
42,349
-13.0%
0.01%
-12.5%
Q1 2021$6,788,000
-24.3%
48,661
-6.0%
0.01%
-27.3%
Q4 2020$8,963,000
+18.7%
51,778
-4.4%
0.01%
+10.0%
Q3 2020$7,548,000
+20.2%
54,184
+3.0%
0.01%
+11.1%
Q2 2020$6,282,000
+25.5%
52,584
+5.1%
0.01%
+12.5%
Q1 2020$5,004,000
-15.4%
50,047
-0.6%
0.01%
-11.1%
Q4 2019$5,918,000
+17.6%
50,347
-14.0%
0.01%
+12.5%
Q3 2019$5,033,000
+34.9%
58,547
+1.7%
0.01%
+33.3%
Q2 2019$3,731,000
+14.4%
57,547
+10.3%
0.01%
+20.0%
Q1 2019$3,262,000
+151.3%
52,185
+56.3%
0.01%
+150.0%
Q4 2018$1,298,000
-6.6%
33,385
+37.0%
0.00%0.0%
Q3 2018$1,389,000
+478.8%
24,363
+638.3%
0.00%
Q4 2016$240,000
-14.6%
3,300
+22.5%
0.00%
Q3 2016$281,000
+1.1%
2,693
-62.6%
0.00%
Q4 2014$278,0007,2000.00%
Other shareholders
NEVRO CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders